Voyager Therapeutics (VT6.F) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.42
0.11
0.63
1.15

Details

Expected EPS
-0.41897935999999997
Actual EPS
-0.15071199999999998
Surprise EPS
0.27
Surprise Percent
+64.03%

Description

Voyager Therapeutics (VT6.F) has reported earnings of -0.15071199999999998 per share for Q4 2024.

0 Comments

Share your thoughts